Since PD-L1 binding to PD-1 on T cells suppresses anti-tumor immunity (Hirai et al., 2017), the loss of miRNA-mediated inhibition of PD-L1 allows tumor cells to enhance this immunosuppressive signaling. The gene discussed is CD274; the disease is neoplasm.